India  

AstraZeneca admits Covishield vaccines raises rare side-effects risk. How worried should you be?

DNA Wednesday, 1 May 2024 ()
In India, almost 90% of people who received Covid vaccine, received the AstraZeneca vaccine which in India is called Covishield.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia

Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia 03:03

After AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination initiated legal action against Serum Institute of India. Covishield, developed by AstraZeneca and Oxford University, faced scrutiny. Another family shared the plight of their...

You Might Like


💡 newsR Knowledge: Other News Mentions

Oxford–AstraZeneca COVID-19 vaccine Oxford–AstraZeneca COVID-19 vaccine Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca

1 in 3 Covaxin recipients hit by adverse events: Study

Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The..
IndiaTimes
Lok Sabha Elections 2024: SP Chief Akhilesh Yadav Talks Exclusively with Oneindia in Mainpuri, UP [Video]

Lok Sabha Elections 2024: SP Chief Akhilesh Yadav Talks Exclusively with Oneindia in Mainpuri, UP

Watch as Akhilesh Yadav addresses the crowd in Mainpuri, Uttar Pradesh, discussing key issues including unemployment, Covishield vaccination, and the call to end 'Agniveer'. He also highlights Samajwadi Party's preparations in Kannauj and expresses confidence in SP's victory over BJP in the upcoming Lok Sabha Elections 2024. #AkhileshYadav #Mainpuri #UttarPradesh #LokSabhaElections #LokSabhaElections2024 #Elections2024 #Mainpuri #MainpuriElections #SamajwadiParty #AkhileshYadavExclusive #Oneindia ~PR.274~GR.125~HT.98~

Credit: Oneindia    Duration: 02:44Published

AstraZeneca AstraZeneca British pharmaceutical company

AstraZeneca pulls its COVID-19 vaccine from the European market [Video]

AstraZeneca pulls its COVID-19 vaccine from the European market

Credit: FRANCE 24 English    Duration: 01:37Published
AstraZeneca requests European authorisation of Covid vaccine be pulled [Video]

AstraZeneca requests European authorisation of Covid vaccine be pulled

AstraZeneca was the first pharmaceutical laboratory to launch a vaccine on the market at the end of 2020, a year after the appearance of the virus.

Credit: euronews (in English)    Duration: 00:35Published
AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court [Video]

AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court

AstraZeneca has globally withdrawn its Covid vaccine, citing commercial reasons. The company voluntarily revoked its marketing authorization and announced the cessation of vaccine production, rendering it unusable. This decision marks a significant development in the global vaccination effort against Covid-19. #COVID19 #Astrazeneca #COVIDVaccine #Covishield #Worldnews #Indianews #UKCourt #Oneindia #Oneindianews ~PR.320~ED.102~

Credit: Oneindia    Duration: 05:11Published

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Those who allied with the Congress betrayed voters: Mahayuti's Naresh Mhaske

Naresh Mhaske, a close confidante of Chief Minister Eknath Shinde and former mayor, discusses his challenges and plans as the Mahayuti candidate for parliament...
IndiaTimes

Covaxin had much lower adverse effects and overall favourable short-term safety profile in adolescents: Study

Bharat Biotech’s indigenously developed Covid-19 vaccine Covaxin was overall found to have “much lower” AEFI (adverse effects following immunisation) rates..
IndiaTimes
How the EU is plotting a course out of COVID debt to greener future [Video]

How the EU is plotting a course out of COVID debt to greener future

The next EU Commission will have to cope with a legacy of debt accummulated out of necessity by its predecessor in response to the Covid crisis and the Ukraine War. Instruments are in place to both control debt and invest in the future, but challenging times lie ahead.

Credit: euronews (in English)    Duration: 00:56Published
From crisis to cooperation: how the EU handled the troubled 2019-2024 era [Video]

From crisis to cooperation: how the EU handled the troubled 2019-2024 era

The current EU Parliament and Commission had just begun the work of their five-year agenda when it was derailed by Covid-19 and then the Ukraine war. As the institutions' mandate enters a final phase, Real Economy gets the views of key players in Brussels on one of the EU's most difficult chapters.

Credit: euronews (in English)    Duration: 08:00Published

In Patanjali case, SC raps IMA chief: Can’t sit on a couch and lampoon court

Dr. R V Asokan initiated contempt proceedings against Patanjali founders. The Supreme Court, with Judges Hima Kohli and Ahsanuddin Amanullah, criticized Asokan..
IndiaTimes

Related videos from verified sources

Political uproar in India after Astrazeneca admits blood clot side effect [Video]

Political uproar in India after Astrazeneca admits blood clot side effect

A political controversy has erupted in India after British pharma giant Astrazeneca admitted in the UK court that it's Covid-19 vaccine to blood clots in "very rare cases"...

Credit: Rumble     Duration: 06:02Published
Bombshell Astrazeneca Vaccine Faces Big Lawsuit Admit Side Effects Over Rare Blood Clot [Video]

Bombshell Astrazeneca Vaccine Faces Big Lawsuit Admit Side Effects Over Rare Blood Clot

Bombshell Astrazeneca Vaccine Faces Big Lawsuit Admit Side Effects Over Rare Blood Clot .. please like subscribe

Credit: Rumble     Duration: 02:02Published